[PLX] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
31-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -58.78%
YoY- -1,779.35%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 14,183 8,753 16,085 8,549 12,054 6,427 11,320 16.20%
PBT -3,567 -5,334 -2,286 -6,667 -4,199 -11,241 -5,475 -24.82%
Tax 442 -190 416 908 96 128 2,207 -65.73%
NP -4,009 -5,144 -2,702 -6,667 -4,199 -11,241 -5,475 -18.74%
Tax Rate - - - - - - - -
Total Cost 18,192 13,897 18,787 15,216 16,253 17,668 16,795 5.46%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -28.27 -58.77 -16.80 -77.99 -34.83 -174.90 -48.37 -30.07%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.08 -0.11 -0.06 -0.15 -0.09 -0.25 -0.14 -31.11%
EPS Diluted -0.08 -0.11 -0.06 -0.15 -0.09 -0.25 -0.14 -31.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.